Asenapine Approved as First Transdermal Patch for Treatment of Schizophrenia

Article

Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.

Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.

Asenapine is a once-daily, transdermal drug delivery system that is indicated to help mitigate some of the challenges patients face with the management of their schizophrenia. The patch provides sustained concentrations during the suggested wear time of 24 hours.

The approval comes after an international, phase 3 study that included 616 adult participants with schizophrenia. The 6-week treatment period tested the safety and efficacy of asenapine, and the prescription demonstrated statistically significant improvement in Clinical Global Impression-Severity (CGI-S).

The most common adverse reactions seen through the study were extrapyramidal disorder, application site reaction, and weight gain.

Reference

U.S. FDA approves secuado (asenapine) transdermal system, the first-and-only transdermal patch for the treatment of adults with schizophrenia [news release]. Miami, FL & Jersey City, NJ; October 15, 2019: Noven Pharmaceuticals website. http://www.noven.com/PR101519.php. Accessed October 15, 2019.

Related Videos
Pride flags during pride event -- Image credit: ink drop | stock.adobe.com
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
Pharmacy Times Public Health Matters Podcast (logo)
selling mental health medication to man at pharmacy | Image Credit: Syda Productions - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Therapy session -- Image credit: pressmaster | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.